Expansion of Human Hematopoietic Stem Cells for Transplantation: Trends and Perspectives
Overview
Genetics
Affiliations
Umbilical cord blood transplantation is clinically limited by its low progenitor cell content. Ex vivo expansion has become an alternative to increase the cell dose available for transplants. Expansion has been evaluated in several ways such as static cultures combining growth factors or mimicking the natural microenvironment using co-culture systems. However, static cultures have a small volume capacity and therefore large-scale expansion has been addressed using bioreactors. These and other biotechnological approaches for the expansion of hematopoietic progenitors and their utility to study several aspects of hematopoietic stem cell biology are discussed here.
Kojabad A, Esmaeili Gouvarchin Ghaleh H, Shahriary A, Farzanehpour M Indian J Hematol Blood Transfus. 2023; 39(2):173-182.
PMID: 37006970 PMC: 10064360. DOI: 10.1007/s12288-022-01576-4.
Teleb R, Abdul-Hafez A, Othman A, Ahmed A, Elsaid A, Arif H Cells. 2023; 12(2).
PMID: 36672185 PMC: 9857343. DOI: 10.3390/cells12020250.
3D Scaffolds to Model the Hematopoietic Stem Cell Niche: Applications and Perspectives.
Congrains A, Bianco J, Rosa R, Mancuso R, Saad S Materials (Basel). 2021; 14(3).
PMID: 33530372 PMC: 7865713. DOI: 10.3390/ma14030569.
Kang Y, Jeong J, Lee T, Lee H, Shin J Stem Cells Int. 2018; 2018:4527929.
PMID: 29681947 PMC: 5848107. DOI: 10.1155/2018/4527929.
Ex-vivo expansion of nonhuman primate CD34 cells by stem cell factor Sall4B.
Shen B, Zhang Y, Dai W, Ma Y, Jiang Y Stem Cell Res Ther. 2016; 7(1):152.
PMID: 27765075 PMC: 5072326. DOI: 10.1186/s13287-016-0413-1.